Nisha R Acharya
Affiliation: University of California
Rathinam S, Babu M, Thundikandy R, Kanakath A, Nardone N, Esterberg E, et al
. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology. 2014;121:1863-70 pubmed publisher
..However, there was a 22% difference in treatment success favoring methotrexate. ..
Borkar D, Tham V, Esterberg E, Ray K, Vinoya A, Parker J, et al
. Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study. Ophthalmology. 2013;120:451-456 pubmed publisher
..This study provides a population-based estimate of HZO and highlights differences across various age and racial groups. It also suggests that demographic characteristics may be useful in determining the risk of developing HZO. ..
Borkar D, Tham V, Shen E, Parker J, Uchida A, Vinoya A, et al
. Association between statin use and uveitis: results from the Pacific Ocular Inflammation study. Am J Ophthalmol. 2015;159:707-13 pubmed publisher
..Statin use may be protective against the development of uveitis. Several anti-inflammatory and immunomodulatory mechanisms may explain this association. ..
Yuen B, Tham V, Browne E, Weinrib R, Borkar D, Parker J, et al
. Association between Smoking and Uveitis: Results from the Pacific Ocular Inflammation Study. Ophthalmology. 2015;122:1257-61 pubmed publisher
..The association was stronger for noninfectious uveitis. Given the well-established risks of smoking with regard to other inflammatory disorders, these results reaffirm the importance of encouraging patients to avoid or cease smoking. ..
Sy A, O Brien K, Liu M, Cuddapah P, Acharya N, Lietman T, et al
. Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED). BMC Ophthalmol. 2015;15:133 pubmed publisher
..This survey offers insight into current expert opinion in the treatment of DED. The results of this survey are hypothesis generating and will aid in the design of future clinical studies. ..
Schallhorn J, Niemeyer K, Browne E, Chhetri P, Acharya N. Difluprednate for the Treatment of Uveitic Cystoid Macular Edema. Am J Ophthalmol. 2018;191:14-22 pubmed publisher
..Difluprednate was associated with an improvement in uveitic CME and could be a reasonable first-line therapy. IOP should be closely monitored. ..
Shen E, Rathinam S, Babu M, Kanakath A, Thundikandy R, Lee S, et al
. Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies. Am J Ophthalmol. 2016;168:279-286 pubmed publisher
..Although patients with acute VKH gained more visual improvement than those with chronic VKH, this did not correspond with a higher rate of controlled inflammation. ..
Acharya N, Srinivasan M, Kundu A, Lietman T, Whitcher J, Cunningham E. Mooren''s ulcer following extracapsular cataract extraction. Eur J Ophthalmol. 2008;18:351-5 pubmed
..Prior cataract surgery is a recognized risk factor for the development of Mooren''s ulcer, but the demographic and clinical features of a large cohort of such patients have not been described...
Acharya N, Hong K, Lee S. Ranibizumab for refractory uveitis-related macular edema. Am J Ophthalmol. 2009;148:303-309.e2 pubmed publisher
..Intravitreal ranibizumab led to an increase in VA and regression of uveitis-associated CME in patients refractory to or intolerant of standard corticosteroid therapy. Further studies of this promising treatment are warranted. ..